Atiprimod Completed Phase 2 Trials for Neuroendocrine Carcinomas Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| https://clinicaltrials.gov/ct2/show/ | Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma | |
| https://clinicaltrials.gov/ct2/show/ | Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma |